Showing results (61-70 of 165) with videos related to
Sort By:
Pageof 17
The Journal of Antimicrobial Chemotherapy|August 15, 2003
Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reductionPaul G Ambrose, Sujata M Bhavnani, Brenda B Cirincione, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2003
Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogensSujata M Bhavnani, Jeffrey P Hammel, Alan Forrest, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2009
Lack of MyD88 protects the immunodeficient host against fatal lung inflammation triggered by the opportunistic bacteria Burkholderia cenocepaciaGrasiella M de C Ventura, Viviane Balloy, Reuben Ramphal, et al.Antimicrobial Agents and Chemotherapy|August 30, 2005
Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenemSujata M Bhavnani, Jeffrey P Hammel, Brenda B Cirincione, et al.Diagnostic Microbiology and Infectious Disease|January 21, 2006
Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance ProgramSujata M Bhavnani, Paul G Ambrose, William A Craig, et al.Antibiotics (Basel, Switzerland)|July 19, 2020
Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and ThriveM Courtney Safir, Sujata M Bhavnani, Christine M Slover, et al.Diagnostic Microbiology and Infectious Disease|October 12, 2004
Pharmacokinetics, safety, and tolerability of ascending single intravenous doses of oritavancin administered to healthy human subjectsSujata M Bhavnani, Joel S Owen, Jeffery S Loutit, et al.Antimicrobial Agents and Chemotherapy|November 9, 2016
Bacterial Replication Rate Modulation in Combination with Antimicrobial Therapy: Turning the Microbe against ItselfPaul G Ambrose, Brian VanScoy, Haley Conde, et al.Antimicrobial Agents and Chemotherapy|December 30, 2015
Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit ConsiderationsSujata M Bhavnani, Paul G Ambrose, Jeffrey P Hammel, et al.American Journal of Respiratory and Critical Care Medicine|August 17, 2013
Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputumAlice V Dubois, Patrick Midoux, Delphine Gras, et al.Pageof 17